Structure of the BfArM (PDF, 127KB, File is accessible)

P
President
Prof. Dr. Karl Broich
3704
P11
Media and Public Relations
Research Council
Research Co-ordinator
P13
Ombudsman,
Change and Idea
Management
Dr. Schulte, A.
Pommer, M.
N.N.
3261
Secr. 0228-99-307-3219/ -3204
Telefax: 0228-99-307-5514
P3
Controlling/ E-Processes
PD Dr. Enzmann, H.
Dr. Scheffler, M.
Secr. 3314
VP
3309
P2
European and International Affairs
3689
3816
Vice President
P21
CMDh
Prof. Dr. Julia Stingl
3575
PharmNet.Bund Authorised
Representative
Dr. Menges, K.
Dir. und Prof. 3458
Equal Opportunity
Commissioner
Mertens, R.
Personnel Development
Organisational
Health Care Managment
Division Z
Division 1
Division 2
Division 3
Licensing 1
Licensing 2
Licensing 3
N.N.
Dr. Horn, M.
N.N.
4310
Secr. 3568
Winterscheid, S.
Secr. 3532
Z11
Human Resources
11
Validation
Füllmann, J.
21
Project
Management
Dr. Deicke, A.
5855
22
Gastroenterology/Metabolic
Disorders/Radiology
Dr. Dussa, J.
Dr. Meyer, R.
4705
13
Simplified Procedures II
Meyer, U.
5945
23
Diabetes Mellitus/
Cardiovascular System
Eibenstein, M.A., G.
5660
5844
Dr. Weise, M.
5482
Dr. Diller, M.
4011
42
Phytotherapeutic and
Traditional Medicinal
Products
Reh, K.
5341
33
Anaesthesiology/Algesiology/Rheumatology/
Pneumology
Dr. Schriever. J.
3304
43
Homoeopathic and
Anthroposophic Medicinal
Products
Dr. von der Heidt, C.
3361
14
Parallel Imports
24
Oncology/Endocrinology
34
Neurology/Psychiatry/
Ophthalmology
Kaiser, M.
Dr. Brendler-Schwaab, S.
3526
Dr. Hermes, U.
Dr. Rems, L.
3686
Z15
Library
3188
25
Genetic and Reproductive
Toxicology
Duda, A.
PD Dr. Röhrdanz, E.
3235
3335
5975
32
Antiinfectives/Antiallergics/
Dermatology/ENT
Matz, S.
3355
Z14
E-Portal,
Document Management
Dr. Naumann-Winter
3466
Division 7
Division 8
Division 9
Federal Opium Agency
Medical Devices
Prof. Dr. Stingl, J.
PD Dr. Sudhop, T.
3570
Secr. 3571
Dr. Kirchner, C.
5301
Dr. Paeschke, N.
4360
Secr. 3129
Prof. Dr. Stingl, J. **
3570
52
Research Group
Pharmacoepidemiology
Prof. Dr. Stingl, J.**
Dir.‘in u. Prof.‘in
3570
53
Research group on
clinical safety of
implants
N.N.
4112
Secr. 3311
61
Clinical Trials
Dr. Dr. Schrödter, A.
4320
Dr. Palissa, H.
4043
62
Scientific Advice
72
PRAC and other
Commitees
N.N.
Dr. Huber, M.
63
Expert Panels
Dr. Riedel, C.
4110
54
Biostatistics and Special
Pharmacokinetics
64
Legal Affairs
PD Dr. Benda, N.
Völkel, H.
3514
4218
73
Post-authorisation Safety
Studies,
Pharmacovigilance
Centres,
Pharmacoepidemiology
Dr. Straßmann, V.
3538
74
Signal Detection,
Validation and Evaluation,
ADR, Medication Safety
4519
Dr. Norwig, J.
3274
Raunitschke, R.
4517
3767
Z17
Internal Services,
Property Matters
75
Risk Assessment
Procedures,
Pharmacovigilance
Inspections
Dr. Zimmermann, L.
3232
4236
5944
3820
* temporarily charged with the conduct of affairs/
interim performance of the funktions
** temporary in addition to the function as the Head of
Division
5934
Social Advice
Data Protection
Commissioner
Dexel, F.
Claar, B.
4000
4503
3732
81
Control of Legal Trade in
Precursors, Thalidomide
Register
Rohr, A.
5104
91
Project Management and
Scientific Cross-sectional
Issues
Dr. Rämsch-Günther, N.
3997
82
Control of Legal Trade in
Narcotics and Psychotropic
Substances I and Safety
Measures
Dr. Bräutigam, B.
5127
92
Non-active Medical Devices
83
Control of Legal Trade in
Narcotics and Psychotropic
Substances II
Dr. Greve, H.
5108
93
Active Medical Devices and
In-vitro
84
Issues Relating to
Pharmacists and Physicians
Todt, M.
Dr. Zündorf, J.
3202
Dr. Stößlein, E.
5384
94
Clinical Trials
Dr. Schriever, U. *
4137
95
Methods Research
Medical Devices Safety
Dr. Lauer, W. *
5355
Dr. Lütkehermölle, W.
3216
Dr. Grüger, Th.
Skiba, D.
5355
76
Risk Management I
77
Risk Management II
Sent, J.
Dr. Lauer, W.
Secr. 5325
5984
Dr. Alesik, E.
3660
65
Pharmacopoeia
Dr. Cremer-Schaeffer, P.
3316
Secr. 5102
71
Project
Management
66
Information Technology
Representative for Disabled
Employees
Mertes-Engel, N.
3816
Pharmacovigilance
Dr. Göben, J.
Hulbert, F.
Dr. Scheffler, M.
3762
3363
Division 6
Z16
Special Legal Issues,
Licensing Fees
Head of the
Staff Advisory Committee
Hammerl, A.
P33
Quality Management
Scientific Services
35
Pharmaceutical
Biotechnology,
Quality Inspections
Dr. Brake, B.
3482
Makran, S.
P32
Controlling
Research
5692
Youth and Trainees
Council
P31
E-Processes
Division 5
51
Research Group
Pharmcogenomics
41
Project
Management
Stadler, B.*
3133
12
Simplified Procedures I
Ludwig-Merseburg, S.
3866
Z13
Organisational Issues,
Knowledge Management
31
Project
Management
Norta, M.
3393
Z12
Budget
Division 4
Licensing 4
Complementary and Traditional
Medicinal Products
Prof. Dr. Knöss, W.
4172
5638
Secr. 5334
3315
Secr. 3333
Dr. Bachmann, P.
4163
P23
Scientific Quality/
Peer review
Dr. Limberg, J.
Secr. 0228-99-307-3576/ -3897
Telefax: 0228-99-307-3217
5211
Administration
P22
COMP
Structure of the
Federal Institute for Drugs
and Medical Devices
(BfArM)
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Telefon: (0228) 99-307 – 30
Telefax:
(0228) 99-307 – 5207
E-Mail:
[email protected]
Stand: 26.04.2016
5938